– AuriNovo™ an investigational, 3D-bioprinted implant was created using a proprietary process leveraging the patient’s own tissue to generate an implantable ear – – Phase 1/2a clinical trial enrolling patients with microtia, a rare congenital disorder where reconstruction options are limited – – AuriNovo™ granted Orphan Drug and Rare Pediatric Disease Designations by the U.S. … [Read more…]

Mittelstand companies face inevitable uncertainty, business challenges and rising geopolitical tensions head-on in the year ahead FRANKFURT, Germany–(BUSINESS WIRE)–Nearly all (95%) German Mittelstand leaders expect business repercussions from the war in Ukraine for at least six months, up 14% from March, citing higher energy prices (50%), commodity prices (47%) and inflation (38%) as the top … [Read more…]

KYOTO, Japan–(BUSINESS WIRE)–Megakaryon Corporation (hereinafter, Megakaryon) today announces its clinical trial of allogenic human iPSC-derived HLA homozygous platelets (Development Code: MEG-002) in collaboration with Kyoto University Hospital, Center for iPS Cell Research and Application, Kyoto University (CiRA) and CiRA Foundation (CiRA_F). Initial administration to the first subject was successful and with no reported adverse events. … [Read more…]

LARGO, Fla.–(BUSINESS WIRE)–CONMED Corporation (NYSE: CNMD) today announced the pricing of $700 million aggregate principal amount of 2.25% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, CONMED … [Read more…]

BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that it will participate in and present at the Jefferies Global Healthcare Conference 2022 on Friday, June 10, 2022 at 12:45 PM ET. A live webcast … [Read more…]

LEXINGTON, Mass.–(BUSINESS WIRE)–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $4.75 per share. The gross proceeds to Concert, before deducting underwriting discounts and commissions and estimated offering expenses payable by Concert, are expected to be approximately … [Read more…]

BROOKLYN, N.Y.–(BUSINESS WIRE)–Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AC0176 for the treatment of patients with metastatic castration resistant prostate cancer (mCRPC) with disease progression on or after treatment with androgen … [Read more…]

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) today called for the redemption of all of the $1.748 billion aggregate principal amount outstanding of its 6.750% senior notes due June 15, 2023 (the “Notes”), which were issued pursuant to the Indenture, dated as of June 16, 2015, among THC Escrow Corporation II and The Bank of New … [Read more…]

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.000 billion in aggregate principal amount of senior secured first lien notes due on June 15, 2030, which will bear interest at a rate of 6.125% per annum (the “notes”). The … [Read more…]

FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd. based in New Jersey, has announced a strategic executive leadership re-organization and expansion of the company’s Executive Committee with the following changes effective July 1, 2022: Nate McCutcheon, currently Shionogi Inc.’s Chief Operating Officer, will be promoted to assume the role … [Read more…]